Inhibiting VEGF could also lead to “normalization” of tumor vasculature, improving oxygen, nutrient, and chemotherapy delivery to increase tumor toxicity and reduce ascites fluid formation13,14. The gene discussed is VEGFA; the disease is neoplasm.